Back to CELG-RI
TRUIST FINANCIAL CORP → CELG-RI
TRUIST FINANCIAL CORP CELG-RI Position History
Bristol-Myers Squibb Company Ce • Healthcare
Quarters held
20
Latest value
$800K
Q3 2026
Peak value
$42.8M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $18.5M |
| Q3 2025 | $3.1M |
| Q3 2025 | $36.7M |
| Q3 2025 | $411K |
| Q4 2025 | $23.7M |
| Q4 2025 | $3.7M |
| Q4 2025 | $37.5M |
| Q4 2025 | $811K |
| Q1 2026 | $31.8M |
| Q1 2026 | $41.1M |
| Q1 2026 | $4.3M |
| Q1 2026 | $788K |
| Q2 2026 | $30.2M |
| Q2 2026 | $39.4M |
| Q2 2026 | $4M |
| Q2 2026 | $934K |
| Q3 2026 | $32.8M |
| Q3 2026 | $3.8M |
| Q3 2026 | $42.8M |
| Q3 2026 | $800K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $800K | 16.3K | — | — |
| Q3 2026 | $42.8M | 685.7K | — | — |
| Q3 2026 | $3.8M | 60.5K | — | — |
| Q3 2026 | $32.8M | 525.2K | — | — |
| Q2 2026 | $934K | 19.5K | — | — |
| Q2 2026 | $4M | 69.6K | — | — |
| Q2 2026 | $39.4M | 683.6K | — | — |
| Q2 2026 | $30.2M | 524.1K | — | — |
| Q1 2026 | $788K | 18.3K | — | — |
| Q1 2026 | $4.3M | 70.3K | — | — |
| Q1 2026 | $41.1M | 677.6K | — | — |
| Q1 2026 | $31.8M | 524.2K | — | — |
| Q4 2025 | $811K | 18.2K | — | — |
| Q4 2025 | $37.5M | 694.7K | — | — |
| Q4 2025 | $3.7M | 68.5K | — | — |
| Q4 2025 | $23.7M | 439.0K | — | — |
| Q3 2025 | $411K | 9.5K | — | — |
| Q3 2025 | $36.7M | 813.1K | — | — |
| Q3 2025 | $3.1M | 67.9K | — | — |
| Q3 2025 | $18.5M | 410.5K | — | — |
Other funds holding CELG-RI
$11.1B
$9.6B
$8.5B
$7.9B
$5.9B
$5.9B
$5.8B